SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $827,348 | +118.1% | 30,009 | +137.8% | 0.02% | +110.0% |
| Q2 2023 | $379,327 | -77.5% | 12,619 | -72.9% | 0.01% | -78.3% |
| Q1 2023 | $1,685,238 | +99.7% | 46,515 | +96.6% | 0.05% | +91.7% |
| Q4 2022 | $843,952 | +127.5% | 23,660 | +96.3% | 0.02% | -22.6% |
| Q2 2021 | $371,000 | +38.4% | 12,054 | +13.2% | 0.03% | +10.7% |
| Q4 2020 | $268,000 | +4.3% | 10,650 | -1.7% | 0.03% | +86.7% |
| Q4 2019 | $257,000 | -91.2% | 10,832 | -86.9% | 0.02% | -92.7% |
| Q1 2019 | $2,905,000 | +42.5% | 82,901 | +35.1% | 0.21% | +62.2% |
| Q4 2018 | $2,039,000 | +255.2% | 61,377 | +326.5% | 0.13% | +101.6% |
| Q4 2017 | $574,000 | +3.2% | 14,392 | -34.6% | 0.06% | -28.4% |
| Q4 2016 | $556,000 | -45.9% | 22,000 | -67.4% | 0.09% | -26.7% |
| Q1 2016 | $1,028,000 | +39.5% | 67,382 | +22.9% | 0.12% | +84.6% |
| Q4 2015 | $737,000 | +3.4% | 54,815 | -7.1% | 0.06% | -11.0% |
| Q1 2015 | $713,000 | – | 59,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |